TechsoMed
2 known investors
Find your way into TechsoMed
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.
Founders & leadership
YA
Yossi Abu
DM
Dasy Mandel
NE
Nitzan Even
YZ
Yogev Zohar
DF
Dubi Finklshtein
Investors · 2
Funding
SEC filings, press & company announcements$7M disclosed across 1 round · 2021
- $7MSeries BMar 2021 · 2 sources
Axil Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does TechsoMed do?
- TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.
- Who are TechsoMed's investors?
- TechsoMed's investors include NextLeap Ventures, Axil Capital.
- How much funding has TechsoMed raised?
- TechsoMed has disclosed $7M raised across 1 round.